The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.
FDA Approves Evrysdi Tablet from Roche for Spinal Muscular Atrophy
The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.